The role of adoptive immunotherapy in solid cancers.
Kruit
W H
WH
Department of Medical Oncology, Rotterdam Cancer Institute/University Hospital Rotterdam, Netherlands.
Stoter
G
G
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D008545:Melanoma / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007376:Interleukin-2